Evidence map›Paper›PMID 28887533›Full record

ArticleScientific reports2017

Creation and Initial Characterization of Isogenic Helicobacter pylori CagA EPIYA Variants Reveals Differential Activation of Host Cell Signaling Pathways.

Dacie R Bridge, Faith C Blum, Sungil Jang, Jinmoon Kim, Jeong-Heon Cha, D Scott Merrell

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Frontiers in microbiology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Correlation analysis of gastric mucosal lesions withAnnals of translational medicine · 2022
    Article
  8. CagA and VacA inhibit gastric mucosal epithelial cell autophagy and promote the progression of gastric precancerous lesions.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  9. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  10. Article
  11. EPIYA motifs ofNew microbes and new infections · 2021
    Article
  12. Cells · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Dacie R BridgeUniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Department of Microbiology and Immunology, Bethesda, Maryland, 20814, USA.ORCID 0000-0001-9048-0594
Faith C BlumUniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Department of Microbiology and Immunology, Bethesda, Maryland, 20814, USA.
Sungil JangDepartment of Oral Biology, Oral Science Research Center, Yonsei University College of Dentistry, Seoul, South Korea.
Jinmoon KimDepartment of Oral Biology, Oral Science Research Center, Yonsei University College of Dentistry, Seoul, South Korea.
Jeong-Heon ChaDepartment of Oral Biology, Oral Science Research Center, Yonsei University College of Dentistry, Seoul, South Korea.
D Scott MerrellUniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Department of Microbiology and Immunology, Bethesda, Maryland, 20814, USA. douglas.merrell@usuhs.edu.
Yonsei University · KRUniformed Services University of the Health Sciences · USUniversity of Maryland, Baltimore · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2003 to 2013
$91.5M
Helicobacter pylori CagA toxin polymorphismR21AI121517 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MERRELL, D. SCOTT · 2016 to 2017
$420k
Transcriptional Control of Helicobacter pylori VirulenceR21AI109405 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MERRELL, D. SCOTT · 2014 to 2015
$418k
NIAID NIH HHS R21 AI109405NIAID NIH HHS R21 AI121517NIAID NIH HHS U54 AI057168
6 · The paper itself

Abstract

The polymorphic CagA toxin is associated with Helicobacter pylori-induced disease. Previous data generated using non-isogenic strains and transfection models suggest that variation surrounding the C-terminal Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs as well as the number of EPIYA motifs influence disease outcome. To investigate potential CagA-mediated effects on host cell signaling, we constructed and characterized a large panel of isogenic H. pylori strains that differ primarily in the CagA EPIYA region. The number of EPIYA-C motifs or the presence of an EPIYA-D motif impacted early changes in host cell elongation; however, the degree of elongation was comparable across all strains at later time points. In contrast, the strain carrying the EPIYA-D motif induced more IL-8 secretion than any other EPIYA type, and a single EPIYA-C motif induced comparable IL-8 secretion as isolates carrying multiple EPIYA-C alleles. Similar levels of ERK1/2 activation were induced by all strains carrying a functional CagA allele. Together, our data suggest that polymorphism in the CagA C-terminus is responsible for differential alterations in some, but not all, host cell signaling pathways. Notably, our results differ from non-isogenic strain studies, thus highlighting the importance of using isogenic strains to study the role of CagA toxin polymorphism in gastric cancer development.

Indexed as

Amino Acid MotifsHost-Pathogen InteractionsSignal TransductionAntigens, BacterialBacterial ProteinsCell LineEpithelial CellsHelicobacter pyloriHumansMutant ProteinsVirulence FactorsAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pyloriMutant ProteinsVirulence Factors

Identifiers

PMID28887533
PMCPMC5591203
OpenAlexW2753348318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.